Gabriel Caruso Novaes Tudella

Gabriel Caruso Novaes Tudella

Auto-generated profile, based on publicly available information

Gabriel Caruso Novaes Tudella

Department of Medicine, Federal University of Santa Maria, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2025 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
GTGabriel Caruso Novaes Tudella
Gabriel Caruso Novaes Tudella
CFCamila Sales Fagundes
Camila Sales Fagundes
TCTaíne De Conto
Taíne De Conto
MMMateus Diniz Marques
Mateus Diniz Marques
DCDiego Chemello
Diego Chemello

29 March 2026 in Acta Tropica
Verified
Journal Article
Closed access
GTGabriel Caruso Novaes Tudella
Gabriel Caruso Novaes Tudella
FSFelipe Yuji Sasazaki
Felipe Yuji Sasazaki
IKIsabella Kelnhar
Isabella Kelnhar
TCTaíne de Conto
Taíne de Conto
JOJuliane Valim Barcellos de Oliveira
Juliane Valim Barcellos de Oliveira
JWJuliana da Rosa Wendt
Juliana da Rosa Wendt

14 July 2026 in Neurology
Verified
Journal Article
Closed access
PDF file
MPMaria Antônia Oliveira Machado Pereira
Maria Antônia Oliveira Machado Pereira
GTGabriel Caruso Novaes Tudella
Gabriel Caruso Novaes Tudella
AKAugusto Utida Klostermann
Augusto Utida Klostermann
VOVictor Arthur Ohannesian
Victor Arthur Ohannesian
OGOcílio Ribeiro Gonçalves
Ocílio Ribeiro Gonçalves
KAKelson James Almeida
Kelson James Almeida
Background and ObjectivesParkinson disease (PD) is a progressive neurodegenerative disorder increasingly linked to gut microbiota dysbiosis, which may influence disease mechanisms and symptom expre...

31 July 2026 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Closed access
GTGabriel Caruso Novaes Tudella
Gabriel Caruso Novaes Tudella
MPMaria Antônia Oliveira Machado Pereira
Maria Antônia Oliveira Machado Pereira
AKAugusto Utida Klostermann
Augusto Utida Klostermann
JGJoão Victor Pereira Gonzalez
João Victor Pereira Gonzalez
OGOcílio Ribeiro Gonçalves
Ocílio Ribeiro Gonçalves
SVSilvânia Maria Mendes Vasconcelos
Silvânia Maria Mendes Vasconcelos
Background: Alpha-lipoic acid (ALA) is an antioxidant proposed to mitigate metabolic burden and psychopathology in schizophrenia. We systematically reviewed the efficacy and safety of ALA as an adjunct to antipsychotics. Methods: We searched MEDLINE, Embase, and the Cochrane Library from inception to September 2025 for human studies evaluating ALA in individuals with schizophrenia. Random-effects meta-analyses pooled mean differences (MDs) with 95% CIs for continuous outcomes and pooled proportions for adverse events and discontinuation. Results: Eight studies (n = 165) were included. In single-arm analyses, ALA showed no significant improvements in PANSS scores in pooled estimates, despite isolated findings in small subsets. A reduction in BMI was observed in the RCT subgroup but not in the overall analysis. No significant effects were found for HbA1c, waist circumference, or lipid profile. In ALA versus placebo comparisons, no significant differences were observed for PANSS scores, BMI, adverse events, or discontinuation. ALA was generally well tolerated, though findings were limited by small sample sizes and imprecision. Conclusions: Current evidence suggests adjunctive ALA may modestly influence selected PANSS subscales but does not improve metabolic outcomes. Larger, well-designed trials with standardized dosing and longer follow-up are needed to clarify clinical relevance and safety.

29 August 2026 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Open access
ASAnderson Matheus Pereira Da Silva
Anderson Matheus Pereira Da Silva
DLDaniel Vicente de Siqueira Lima
Daniel Vicente de Siqueira Lima
LCLeonardo Januário Campos Cardoso
Leonardo Januário Campos Cardoso
GTGabriel Caruso Novaes Tudella
Gabriel Caruso Novaes Tudella
ALAlice Mi Lee
Alice Mi Lee
GPGeorge Perry
George Perry

2 July 2025 in Revista Enfermagem Atual In Derme
Verified
Journal Article
Open access
MSMariane Cândido da Silva
Mariane Cândido da Silva
MGMaria José Quina Galdino
Maria José Quina Galdino
BNBárbara Letícia Barbosa Do Nascimento
Bárbara Letícia Barbosa Do Nascimento
AEAmanda Da Silva Estampreski
Amanda Da Silva Estampreski
GTGabriel Caruso Novaes Tudella
Gabriel Caruso Novaes Tudella
ASAlessandro Rolim Scholze
Alessandro Rolim Scholze
Objetivo: Analisar a prevalência e fatores associados à ideação suicida entre enfermeiros antes, durante e após a pandemia da COVID-19. Método: Protocolo de revisão sistemática, seguindo as diretrizes do Joanna Briggs Institute e do Preferred Reporting Items for Systematic Reviews and Meta-Analyses. As buscas serão realizadas em seis fontes de busca: MEDLINE/PubMed, SCOPUS, EMBASE, LILACS, Cochrane Central e Google Acadêmico. Serão incluídos estudos com enfermeiros que desenvolveram ideação suicida ocorrendo em serviços de saúde, antes, durante e após a COVID-19. A seleção dos estudos, revisão de dados e avaliação crítica serão realizadas de forma independente por dois revisores, com um terceiro para resolver discrepâncias. Propõe-se desenvolver uma descrição estatística com metanálise, se adequada. Resultados esperados: Espera-se identificar a prevalência de ideação suicida e seus fatores associados entre enfermeiros, fornecendo subsídios para o desenvolvimento de políticas públicas para a saúde do trabalhador e estratégias de saúde mental.